BOOTS-CELLTECH DIAGNOSTICS LIMITED – Trademark Portfolio
Entity Type: 16
BOOTS-CELLTECH DIAGNOSTICS LIMITED holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 5 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include IDEIA and IMAGEN. The owner is based in SLOUGH, BERKS.
240 BATH ROAD
SLOUGH, BERKS , GB
Showing of trademarks Trademarks
Trademark Classifications
BOOTS-CELLTECH DIAGNOSTICS LIMITED's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does BOOTS-CELLTECH DIAGNOSTICS LIMITED have?
BOOTS-CELLTECH DIAGNOSTICS LIMITED has 6 U.S. trademarks filed with the USPTO. Of these, 2 registered, 4 cancelled.
What trademark classes does BOOTS-CELLTECH DIAGNOSTICS LIMITED file in?
BOOTS-CELLTECH DIAGNOSTICS LIMITED files trademarks across 2 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 9 (Computers & Electronics). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are BOOTS-CELLTECH DIAGNOSTICS LIMITED's most well-known trademarks?
BOOTS-CELLTECH DIAGNOSTICS LIMITED's registered trademark portfolio includes well-known marks such as IDEIA and IMAGEN. These are among 2 currently registered trademarks in the portfolio.
What is BOOTS-CELLTECH DIAGNOSTICS LIMITED's trademark registration success rate?
BOOTS-CELLTECH DIAGNOSTICS LIMITED has a 33% trademark registration rate, with 2 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.